Prostate cancer laboratory studies: Difference between revisions

	Prostate cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Prostate Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Staging
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Biopsy
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Alternative Therapy
Case Studies
Case #1
Prostate cancer laboratory studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Prostate cancer laboratory studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Prostate cancer laboratory studies
CDC on Prostate cancer laboratory studies
Prostate cancer laboratory studies in the news
Blogs on Prostate cancer laboratory studies
Directions to Hospitals Treating Prostate cancer
Risk calculators and risk factors for Prostate cancer laboratory studies

Revision as of 14:48, 18 September 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory findings consistent with the diagnosis of prostate cancer include elevated serum prostate-specific antigen level, low red blood cell count, elevated blood urea nitrogen, elevated serum creatinine, elevated alkaline phosphatase, and elevated calcium.

Laboratory findings consistent with the diagnosis of prostate cancer include:

@@ Line 23: / Line 23: @@
 [[Category:Urology]]
 [[Category:Types of cancer]]
-[[Category:Needs overview]]
-[[Category:Primary care]]
 {{WH}}
 {{WS}}